Display Settings:

Format

Send to:

Choose Destination
    Account Res. 2008 Jul-Sep;15(3):152-67.

    Industry-sponsored ghostwriting in clinical trial reporting: a case study.

    Source

    Department of Philosophy, California State University, Northridge, California 91330, USA. leemon.mchenry@csun.edu

    Abstract

    In this case study from litigation, we show how ghostwriting of clinical trial results can contribute to the manipulation of data to favor the study medication. Study 329 for paroxetine pediatric use was negative for efficacy and positive for harm. Yet the ghostwritten publication from this study concluded that paroxetine provided evidence of efficacy and safety and continues to be influential. Despite the role of named authors in revisions of the manuscript, the sponsor company remained in control of the message.

    PMID:
    18792536
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Atypon

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk